Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 457-468 of 9179

PR Newswire associated0

Newel Health and Gerresheimer Launch Strategic Collaboration to Support Pharma Companies in the Era of Integrated Digital Therapies

LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children

Business Wire logo

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)

Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation

Business Wire logo

Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 2026

New study reveals promising new way to find serious liver disease earlier

PR Newswire associated0

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia

Business Wire logo

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure

Business Wire logo

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure

Business Wire logo

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events

PR Newswire associated0

Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors

  • Prev Page
  • 1
  • 2
  • …
  • 38
  • 39
  • 40
  • …
  • 764
  • 765
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us